Industry

– This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement – Pemazyre is the only FGFR inhibitor with multiple indications WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that … [Read more…]

Submission follows application for Omicron BA.1-adapted bivalent vaccine submitted in July If authorized, both Omicron BA.1-adapted and Omicron BA.4/BA.5-adapted bivalent vaccines will be available in the European Union as early as September NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Women’s Digital Health Market Research Report by Type (Diagnostic Tools, Mobile Apps, and Wearable Devices), Distribution Channel, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Women’s Digital Health Market size was estimated … [Read more…]

ST. JOHN’S, Newfoundland and Labrador–(BUSINESS WIRE)–This week, the four conservative Atlantic premiers, along with Ontario’s Premier Ford, announced their idea of bringing in privatization in healthcare, instead of dealing with the recruitment and retention crisis. The premiers floated the idea of publicly funded but privately operated health care services. CUPE Newfoundland and Labrador, which represents … [Read more…]

MADRID–(BUSINESS WIRE)–The polypill developed by the CNIC and Ferrer, which includes three drugs (aspirin, an angiotensin-converting enzyme (ACE) inhibitor, and a statin), is effective at preventing secondary adverse cardiovascular events in people who have previously had a heart attack. The polypill reduces mortality from cardiovascular causes in this population by 33%. This is the finding … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Supply & Logistics for Pharmaceutical Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Clinical Trial Supply & Logistics for Pharmaceutical Market is projected to reach USD 30.59 billion by 2027 from USD 19.60 billion in 2021, at a CAGR 7.69% during the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Suppositories Market (2022-2027) by Type, Base, Distribution Channel, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Suppositories Market is estimated to be USD 1.56 Bn in 2022 and is expected to reach USD 2.05 Bn by 2027, … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Badrul Chowdhury, M.D., Ph.D., has resigned from his role as Chief Medical Officer, effective September 9, 2022. “We appreciate Dr. Chowdhury’s contributions during his tenure with the company,” said Matt Pauls, Chair and CEO, Savara. “His … [Read more…]

GUILFORD, Conn.–(BUSINESS WIRE)–Aug. 26, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first-next generation single-molecule protein sequencing platform, today announced that it will be participating in the Morgan Stanley 20th Annual Global Healthcare Conference taking place at the Sheraton New York, NY, on September 12-14, 2022. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Monoclonal Antibodies Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Source, Production Method, Indication, Application, and End-User” report has been added to ResearchAndMarkets.com’s offering. The monoclonal antibody market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; it is expected to grow at a … [Read more…]